Genome-wide association analysis of psoriasis patients treated with anti-TNF drugs.

导出原文传递

翻译打印收藏纠错

作者： María C,Ovejero-Benito ^[1] ; Ester,Muñoz-Aceituno ^[2] ; David,Sabador ^[1] ; Berta,Almoguera ^[3] ; Rocío,Prieto-Pérez ^[4] ; Hakon,Hakonarson ^[1] ; Pablo,Coto-Segura ^[4] ; Gregorio,Carretero ^[5] ; Alejandra,Reolid ^[6] ; Mar,Llamas-Velasco ^[7] ; Francisco,Abad-Santos ^[2] ; Esteban,Daudén ^[2]

作者单位： Clinical Pharmacology Department, Hospital Universitario de la Princesa, Instituto Teófilo Hernando, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria la Princesa (IIS-IP), Madrid, Spain. ^[1] Dermatology Department, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain. ^[2] Hospital Universitario Fundación Jiménez Díaz (HUFJD). CIBERER, Madrid, Spain. ^[3] Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. ^[4] Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. ^[5] Dermatology Department, Hospital Alvarez Buylla, Mieres, Spain. ^[6] Dermatology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain. ^[7] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. ^[8]

关键词 biological drugs biomarkers microarray pharmacogenetics pharmacogenomics psoriasis